Here’s a stark reality that demands our attention: ovarian cancer remains the deadliest cancer for women, yet it’s often pushed to the sidelines in terms of awareness and funding. This is a crisis Australia can no longer afford to ignore. Despite affecting nearly 2,000 Australian women annually, ovarian cancer receives only a fraction of the investment its devastating impact warrants. But here’s where it gets even more alarming: more than half of those diagnosed will lose their lives within five years—a survival rate of just 49%, unchanged since 1975. This Ovarian Cancer Awareness Month, the Australia and New Zealand Gynaecological Oncology Group (ANZGOG) is sounding the alarm, calling for urgent action to address this silent epidemic.
And this is the part most people miss: ovarian cancer isn’t just a medical challenge—it’s a symptom of systemic underinvestment. With only 1% of Australian Government medical research funding allocated to this disease over the past 15 years, progress has been stifled. Alison Evans, CEO of ANZGOG, puts it bluntly: ‘This isn’t about scientific capability; it’s about funding priorities. Without investment, breakthroughs stay in labs, and women’s lives remain at stake.’ The barriers are clear: limited treatment options, no early detection tests, vague symptoms often overlooked, and inequitable access to care. These issues are solvable—but only with sustained commitment.
Take Shabnam Gujadhur’s story, for example. Diagnosed at just 30 while working as a medical intern, her journey highlights the challenges of ovarian cancer. Despite her medical background, her symptoms were initially dismissed. It took persistence and a friend’s urging for her to receive a diagnosis. Today, she’s in remission but lives with the constant fear of recurrence. ‘Early detection gave me time,’ she says, ‘but most women aren’t that lucky. We need better research—now.’ Her experience underscores the urgent need for change.
But here’s the controversial part: while Australia boasts world-leading researchers, decades of underfunding have left ovarian cancer outcomes stagnant. Survival rates have barely budged, and women continue to face late diagnoses and limited treatment options. Is this acceptable in a country with such advanced medical capabilities? ANZGOG’s Gynaecological Cancer Transformation Initiative offers a solution—a once-in-a-generation opportunity to revolutionize care, improve quality of life, and save lives. But it requires funding.
Through this initiative, sustained investment could deliver earlier diagnoses, personalized treatments, and equitable outcomes. Imagine a future where fewer families lose mothers, partners, or daughters to this disease. This isn’t just a possibility—it’s within reach, but only if we act now. Here’s a thought-provoking question for you: If ovarian cancer affects so many and has such a high mortality rate, why isn’t it a national priority? Share your thoughts in the comments—let’s spark a conversation that drives change.
This February, ANZGOG | WomenCan is urging the community to support their Appeal, which funds the critical research needed to transform ovarian cancer care. As Alison Evans emphasizes, ‘Awareness is important, but it’s not enough. Research is the key to shifting survival rates and giving women the future they deserve.’ Will you join the fight? Visit www.womencan.org.au/ovarian-cancer-awareness-month to learn more or donate. Together, we can rewrite the story of ovarian cancer in Australia.
